Considering drug safety in an isolated way, i.e., not integrating the drug benefits into a BR statement has been detrimental to patients and the pharmaceutical industry. Over the last years regulatory authorities, patient interest groups and the industry have become more and more interested in structured approaches to benefit risk management.

Date : 14th January 2015 to 14th January 2015

Place : United States, Fremont

Website :http://www.compliance4all.com/

Contact Person:Event Manager

Description:

Considering drug safety in an isolated way, i.e., not integrating the drug benefits into a BR statement has been detrimental to patients and the pharmaceutical industry. Over the last years regulatory authorities, patient interest groups and the industry have become more and more interested in structured approaches to benefit risk management.

Considering drug safety in an isolated way, i.e., not integrating the drug benefits into a BR statement has been detrimental to patients and the pharmaceutical industry. Over the last years regulatory authorities, patient interest groups and the industry have become more and more interested in structured approaches to benefit risk management. will be held in Fremont,United States on date 2015-01-14

---

Deadline for abstracts/proposals : 13th January 2015

Keynote Speakers :

Check the event website for more details.